Skip to main content
PTHS logo
PTHS
(NYSEAMERICAN)
Pelthos Therapeutics Inc.
$24.35-- (--)
Loading... - Market loading

Pelthos Therapeutics (PTHS) Stock Price & Financial Analysis

Pelthos Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$24.01 - $24.79
52-Week High$37.50
52-Week Low$18.19
Open$24.44
Volume18.80K
Average Volume (3M)77.27K
Market Cap80.64M
Shares Outstanding3.31M
Price to Sales (P/S)2.91
Price to Book (P/B)2.30
EV/EBITDA-2.01
Revenue (TTM)27.70M
Net Income (TTM)-51.59M
Free Cash Flow (TTM)-35.38M
EPS (TTM)$-20.29
Profit Margin-186.23%
Operating Margin-157.70%
Return on Equity (ROE)-146.97%
Debt to Equity1.51
50-Day MA$26.77
200-Day MA$25.40
52-Week Change-13.71%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Pelthos Therapeutics

What is the current stock price for PTHS?

As of the latest trading session, PTHS stock trades at $24.35. The 52-week range is $18.19–$37.50, with a day range of $24.01–$24.79.

What is the P/E ratio for PTHS?

The P/E ratio (Price-to-Earnings) for PTHS is shown in the Key Statistics section. This valuation metric helps compare Pelthos Therapeutics Inc. to industry peers.

Does PTHS pay dividends?

Pelthos Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for PTHS?

Based on 1 analyst, the consensus for PTHS is Buy.

What is the market cap of PTHS?

Pelthos Therapeutics's market capitalization is $80.6M, classifying it as a micro-cap company. Pelthos Therapeutics operates in the Healthcare sector within the Biotechnology industry.